Open access
90
Views
0
CrossRef citations to date
0
Altmetric
LETTER
Bevacizumab for the Treatment of High-Grade Meningiomas: Is There New Evidence? [Letter]
Vinicius Trindade Gomes da Silva1 LIM 62, University of Sao Paulo Medical School, Sao Paulo, Brazil;2 AC Camargo Cancer Center, Sao Paulo, Brazil
, Thiago Gebrin1 LIM 62, University of Sao Paulo Medical School, Sao Paulo, Brazil
https://orcid.org/0000-0002-5145-8869
Wellingson Silva Paiva1 LIM 62, University of Sao Paulo Medical School, Sao Paulo, BrazilCorrespondence[email protected]
https://orcid.org/0000-0002-5165-7040
Pages 2453-2454
|
Received 05 Oct 2022, Accepted 12 Oct 2022, Published online: 27 Oct 2022
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.